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Hyponatremia with hyperkalemia in infancy is an uncommon but life-threatening occurrence. In the ﬁrst weeks of life, this
scenario is often associated with aldosterone deﬁciency due to salt-wasting congenital adrenal hyperplasia. However, alternative
diagnosesinvolvinginadequatemineralocorticoidsecretionoractionmustbeconsidered,particularlyforinfantsonemonthofage
or older. We report four infants who presented with profound hyponatremia accompanied by urinary tract infection, ultimately
leading to the diagnosis of transient pseudohypoaldosteronism. Our cases provide support for the idea that the renal tubular
resistance to aldosterone is due to urinary tract infection itself rather than to underlying urinary tract anomalies typically found
in these infants. Awareness of this condition is important so that serum aldosterone, urine sodium, and urine cultures may be
obtained immediately in any infant presenting with hyponatremia and hyperkalemia in whom a diagnosis of congenital adrenal
hyperplasia was not found. Adequate replacement with intravenous saline and antibiotic therapy is suﬃcient to correct sodium
levels over 24–48 hours.
Copyright © 2009 Radha Nandagopal et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Severe hyponatremia with hyperkalemia and dehydration is
an uncommon but life-threatening occurrence in infancy.
Unless there is clear evidence of gastrointestinal ﬂuid losses,
adrenal conditions, particularly congenital adrenal hyperpla-
sia, are high on the diﬀerential diagnosis. As neonatal screen-
ing for CAH is now mandatory in most of the United States
[1], it becomes increasingly important to consider other, less
common, adrenal causes of hyponatremic dehydration. The
major diagnoses in this group include congenital adrenal
hypoplasia (as well as other causes of hypoadrenalism),
isolated aldosterone deﬁciency, medication administration,
and pseudohypoaldosteronism (PHA).
The broad category of PHA includes PHA type 1
(subdivided into primary and transient, or secondary forms)
and PHA type 2 (also known as familial hyperkalemic hyper-
tension). Primary PHA type 1 is generally characterized by
mutations in the mineralocorticoid receptor or in the genes
encoding subunits of the epithelial sodium channel, leading
to renal or generalized resistance to aldosterone [2]. Since
1983, there have been several reports of secondary PHA
in infancy associated with urinary tract abnormalities, and
less commonly, with urinary tract infections (UTI) [3–7].
However, it is our impression that many pediatric specialists,
including intensivists, nephrologists, and endocrinologists,
remain unfamiliar with this condition and its natural
history. We report four infants with hyponatremia and
UTI recently diagnosed with PHA at our institution over
a two-year period. In three, failure to thrive or weight
loss was the presenting feature, and in each the diagnosis
of PHA was not immediately suspected; the last of these
four patients had two episodes of profound hyponatremia
with UTI before the diagnosis was considered. We present
these cases to emphasize that the diagnosis of transient
pseudohypoaldosteronism should be seriously considered
in the dehydrated, febrile, or failing to thrive infant with
hyponatremia.2 International Journal of Pediatric Endocrinology
2. Methods
We retrospectively reviewed the medical histories of four
children admitted to our center and seen by our pediatric
endocrinology service between September 2005 and January
2008. All information was obtained from notes during
our evaluations of each patient and complemented with
laboratory, imaging, and follow-up data obtained from
the electronic medical record. All relevant data, including
pertinent laboratory studies and renal anatomical anomalies
for each patient, are summarized in Table 1.
3.CaseReports
3.1. Patient 1. Patient 1 was a 29-day-old full-term male
transferred to our hospital from an outside facility where he
was being investigated for failure to thrive and was found to
have severe hyponatremia. Five days prior to admission, he
had been evaluated for fussiness by his primary physician
and was switched to a high-calorie formula. He developed
increased irritability and frequent emesis, and his weight was
3% less than birth weight. At the outside facility the serum
sodium was 124mmol/L and serum potassium 8.4mmol/L.
Initial urinary sodium was elevated at 54mmol/L. He was
afebrile when transferred to our Neonatal Intensive Care
Unit with the presumptive diagnosis of congenital adrenal
hyperplasia, started on intravenous saline and hydrocorti-
sone, oral ﬂudrocortisone, and treated for hyperkalemia.
Congenital adrenal hyperplasia was excluded when the 17-
hydroxyprogesterone level was normal; at that point, a
diagnosis of congenital adrenal hypoplasia was considered.
Urinalysis revealed pyuria, and urine culture was posi-
tive for group B Streptococcus. Voiding cystourethrogram
demonstrated left-sided grade 3 to 4 vesicoureteral reﬂux,
and renal sonography demonstrated mild left pelviectasis.
Serum sodium and potassium normalized after several days
of intravenous ﬂuids and antibiotic therapy. The diagnosis
of pseudohypoaldosteronism became apparent when the
serumaldosteronelevelobtainedonadmissionwasmarkedly
elevatedat>33.24 nmol/L (referencerange .083–.44 nmol/L)
(>1200ng/dL; reference range, 3–16ng/dL). The patient
was discharged from the hospital on antibiotic prophylaxis
and sodium chloride supplementation. His electrolyte levels
remained normal during outpatient follow-up, and the
sodium chloride supplementation was discontinued after a
month. At age 2 years, the patient underwent successful
extravesical ureteral reimplantation and had no postopera-
tive hydronephrosis.
3.2. Patient 2. Patient 2 was a 5-week-old full-term male
initially seen by his primary physician for persistently poor
weight gain. His birth history was unremarkable. The patient
had been breast-feeding and was reported to have normal
urine output. Initial sodium in the primary physician’s oﬃce
was 110mmol/L, and initial potassium was 6.8mmol/L,
prompting immediate concern for salt-wasting congenital
adrenal hyperplasia, though the 17-hydroxyprogesterone
on the state neonatal screen was normal. At the local
emergency room, the child was afebrile, but urinalysis was
positive for white blood cells and red blood cells; urine
culture subsequently grew Klebsiella oxytoca. The patient
was referred to our intensive care unit, where antibiotics
and normal saline were provided. Serum aldosterone level
was markedly elevated at 21.74nmol/L (assay normal <.25
nmol/L) (785ng/dL; assay normal <9ng/dL). Renal ultra-
sound demonstrated unilateral hydronephrosis. He was
discharged on prophylactic antibiotics, and four months
later, the child was diagnosed with stage 1 chronic kidney
disease, with marked unilateral pelvocaliectasis and a dilated
and tortuous right ureter. His electrolytes remained normal.
At age 14 months, he underwent a right nephrectomy. He is
no longer on any medications and is doing well.
3.3.Patient3. Patient3wasa7month-oldpreviouslyhealthy
female with an uncomplicated birth history initially seen
by her primary physician for weight loss of over 0.45kg
in a 2-month period. A urinalysis revealed pyuria, and
she was treated with amoxicillin; the urine eventually grew
Klebsiella pneumoniae. There was no history of fever. Serum
electrolytesobtainedatthesametimerevealedhyponatremia
and hyperkalemia, so the patient was referred to our facility.
Her serum sodium on admission was 116mmol/L with
a serum potassium 6.7mmol/L. The serum aldosterone
level was markedly elevated at 28.67 nmol/L (1035ng/dL).
Renal sonogram revealed unilateral hydronephrosis and
hydroureter. In addition to treatment for her urinary tract
infection, the patient was sent home on ﬂudrocortisone.
Her electrolytes remained normal on followup, and the
ﬂudrocortisone was discontinued after 3 weeks. One month
later, a furosemide renal scan showed equal function of
both kidneys, with no evidence of obstruction. She has, to
our knowledge, had no further episodes of urinary tract
infections or electrolyte imbalance.
3.4. Patient 4. Patient 4 was a female born at term with a
duplicate uterus, duplicated right ureter with hydroureter,
aortic coarctation, and a closed myelomeningocele. She
was initially admitted with low-grade fever and emesis at
age 3.5 months. Initial serum sodium was 103mmol/L,
and potassium was 7.4mmol/L. Her urinalysis was positive
for leukocytes, and urine culture grew Klebsiella oxytoca.
Renal sonogram demonstrated resolution of her previous
hydronephrosis and hydroureter. She was treated with
normal saline and antibiotics, and her UTI and hypona-
tremia resolved. Serum aldosterone level was not obtained
at that admission. She was sent home on prophylactic
trimethoprim-sulfamethoxazole.Followupurineculturewas
negative, but three weeks later the patient had another urine
culture, which grew Escherichia coli. At that time, serum
sodium was normal. She was readmitted at age 7 months
with fever, irritability, and poor oral intake, one month
after discontinuation of prophylactic antibiotics. Sodium on
admission was 111mmol/L, potassium 5.7mmol/L. Urine
culture again grew Escherichia coli. DMSA scan revealed
an atrophic right upper pole, though this was diﬃcult to
distinguish from superimposed pyelonephritis. The day after
admission, when her sodium had increased to 127mmol/LInternational Journal of Pediatric Endocrinology 3
Table 1: Characteristics and laboratory data of 4 infants with secondary pseudohypoaldosteronism.
Patient Age at Serum Na Serum K 17-OH-P Aldosterone Urine Na Urine Renal imaging5
presentation (mmol/L)1 (mmol/L)1 (nmol/L)2 (nmol/L)3 (mmol/L)4 microbe
1 29 days 124 8.4 2.15 (71ng/dL) >33.24
(>1200ng/dL)
54 Group B
Streptococcus
Unilateral grade 3-4
VUR, mild pelviectasis
2 5 weeks 110 6.8 2.64 (87ng/dL) 21.74
(785ng/dL)
12 Klebsiella
oxytoca
Unilateral
hydronephrosis
3 7 months 116 6.7 0.69 (23ng/dL) 28.67
(1035ng/dL)
7 Klebsiella
pneumoniae
Unilateral
hydronephrosis and
hydroureter
4 3 months 103 7.8 4.85 (160ng/dL) Not obtained 25 Klebsiella
oxytoca
Resolution of previous
hydronephrosis
4 (event 2) 7 months 111 5.6 Not obtained 9.62
(347ng/dL)
21 Eschericia coli
Atrophic right upper
pole versus
pyelonephritis
1Serum sodium and potassium values at the time of presentation to clinic or emergency room. 217-OH-P = Serum 17-alpha hydroxyprogesterone. 3Normal
range for serum aldosterone: .083–.44 nmol/L (3–16ng/dL). 4Urinary sodium was obtained at least one day after the start of antibiotic therapy in all
cases expect for Patient 1, in whom the urine sample was obtained the day of antibiotic initiation. 5Renal imaging included renal ultrasound, voiding
cystourethrogram (VCUG), and in the case of patient 4 2nd visit, DMSA scan.
after IV normal saline, her serum aldosterone was elevated
at 9.62nmol/L (347ng/dL). By the second day the serum
sodium was normal, and the patient was discharged home
on antibiotic therapy a week later. One month later her
electrolytesremainednormalandurineculturewasnegative.
4. Discussion
Severe hyponatremia in association with hyperkalemia and
dehydrationmaybeseenwithcongenitaladrenalhyperplasia
(CAH), congenital adrenal hypoplasia, and other forms of
hypoadrenalism, isolated aldosterone deﬁciency, or pseudo-
hypoaldosteronism. Currently, 47 of 50 states in the United
Stateshaverequiredandimplementedneonatalscreeningfor
CAH caused by 21-hydroxylase deﬁciency [8]. As newborn
screening for CAH becomes increasingly common in the
United States and in other countries, less common causes
of aldosterone deﬁciency or resistance must be considered
in infants brought to medical attention with signs and
symptoms of salt-wasting. Congenital adrenal hypoplasia, a
rare genetic disorder most commonly caused by mutations
in DAX-1, responsible for the X-linked form of the disease,
causesadrenalinsuﬃciencywithprofoundelectrolyteabnor-
malities; isolated aldosterone deﬁciency due to aldosterone
synthase deﬁciency can present in a similar manner. While
rare in infants and young children, the administration of
nephrotoxic medications (e.g., ACE inhibitors, nonsteroidal
anti-inﬂammatory drugs) should also be considered.
In the setting of hyponatremia and hyperkalemia, the
key ﬁnding of an elevated serum aldosterone strongly
suggests the diagnosis of PHA type 1, especially in the
ﬁrst weeks of life. Renal tubular resistance to aldosterone
has been previously described in patients with a variety of
urinary tract malformations [4, 5, 9–14]. In some cases,
the electrolyte imbalance may lead to life-threatening events
s u c ha sv e n t r i c u l a rﬂ u t t e r[ 15]. However, the condition
may be diﬃcult to diagnose promptly, in part because the
aldosterone assay is generally sent to a reference laboratory,
and results are not available for several days. Thus, the mea-
surement of a urinary sodium level, if possible done prior
to sodium replacement and antibiotic therapy, may reveal
excessive urinary sodium excretion, suggesting aldosterone
deﬁciency or resistance. Family history, laboratory studies,
and the presence of urinary tract malformations may help
to diﬀerentiate primary genetic PHA type 1 from secondary,
or transient, PHA type1.
There remains controversy in the literature regarding
the role of microbial infection versus anatomic anomaly in
the urinary tract as the underlying pathology leading to
mineralocorticoid resistance. Our cases, we believe, support
the view that aldosterone resistance may occur solely in the
setting of a urinary tract infection, and that the association
with urinary tract malformations is due to their high
incidence in infants diagnosed with severe urinary tract
infections. Four other reports in the literature [6, 13, 16,
17] suggest that severe urinary tract infection itself, and
not the combination with an underlying malformation
may cause aldosterone resistance. In the case of patient 4,
earlier hydronephrosis associated with meningomyelocoele
had resolved, but during her second admission she again
presented with a urinary tract infection and evidence of
pseudohypoaldosteronism,suggestingthattheincitingfactor
was the presence of severe renal tubular inﬂammation rather
than urinary tract obstruction. One may speculate that the
reason this condition is almost exclusively seen in infancy
is that the diet of infants is relatively low in sodium. In the
face of increased urinary salt loss, infants are not able to
compensate by increasing salt intake as older children may
be able to do. Our patients represent a slightly older group
than those previously reported by some [3, 16, 17], though
3 of our 4 patients (including the ﬁrst episode in the case4 International Journal of Pediatric Endocrinology
of patient 4) presented at age 3.5 months or younger, in
agreement with the report by Melzi et al. [5], which suggests
that infants 3 months of age or less seem to be at higher risk
for this complication of pyelonephritis.
Our patients also demonstrate the transient nature of
thealdosteroneresistance,distinguishingthisconditionfrom
the known genetic causes of pseudohypoaldosteronism. The
severe inﬂammation of the kidney itself may contribute
to tubular resistance to aldosterone, a phenomenon about
which little has been written [17]. All of our patients
recovered from their electrolyte imbalances promptly with
treatment of their underlying infections and intravenous
saline. Although one would expect to see relatively high
urinesodiuminpatientswithhyponatremiaandaldosterone
resistance, three of our four patients had relatively low
sodium in urine samples obtained after antibiotic therapy
was initiated; this suggests that urinary sodium losses
decrease rapidly upon initiation of antibiotic therapy.
The implications of our cases are twofold. First, the
diagnosis of transient pseudohypoaldosteronism needs to
be a strong consideration in any infant presenting with
hyponatremia and hyperkalemia after the ﬁrst few weeks
of life, by which time most cases of congenital adrenal
hyperplasia have been diagnosed, either based on newborn
screening or a salt-losing crisis. It should be noted that
our patients did not present with the typical ﬁndings
associated with acute urinary tract infection; three of our
four patients did not manifest fever as a sign of urinary
tract infection, so this condition should be considered even
in the afebrile infant with hyponatremia. Urinary sodium,
serum aldosterone, and urine cultures need to be ordered
without delay, and a renal ultrasound should be obtained
if there is pyuria or a positive urine culture. Second, in any
particularly ill infant who has evidence of an upper urinary
tract infection, serum electrolytes should be checked so that
hyponatremia can be detected and treated promptly with
intravenous saline.
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